In the context of recurrent or metastatic oropharyngeal squamous cell carcinoma (OSCC, a form of HNSCC), CDC42 partakes in the pathologic and progressive aspects of the disease by modulating malignant tumor behavior and immune evasion (Chen, Chen & Liu, 2024). Here, CDC42 is linked to cancer.